These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9453962

  • 41. Could the duration of anti-Helicobacter pylori treatment be shorter?
    Sherwood P, Spiller R.
    Dig Liver Dis; 2000 May; 32(4):281-4. PubMed ID: 11515623
    [No Abstract] [Full Text] [Related]

  • 42. Potent gastric acid inhibition in Helicobacter pylori eradication.
    Gisbert JP.
    Drugs; 2005 May; 65 Suppl 1():83-96. PubMed ID: 16335862
    [Abstract] [Full Text] [Related]

  • 43. No need for ulcer drugs after eradicating H. pylori bacteria?
    Harv Mens Health Watch; 2012 Dec; 17(5):8. PubMed ID: 23373115
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [New therapy attempts in duodenal and stomach ulcers].
    Koop H.
    Dtsch Med Wochenschr; 1992 Aug 14; 117(33):1247-50. PubMed ID: 1354156
    [No Abstract] [Full Text] [Related]

  • 46. [Famotidine treatment of patients with gastric and duodenal ulcers. A comparative study with once or twice-a-day administration].
    Bonardelli P, Fujita Y, Fujita R, Sugata F.
    Clin Ter; 1987 Aug 15; 122(3):183-7. PubMed ID: 2904317
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Helicobacter pylori and tolerance to H2-blockers.
    Zentilin P, Savarino E, Savarino V.
    Aliment Pharmacol Ther; 2005 Feb 01; 21(3):289-90; author reply 290-1. PubMed ID: 15691304
    [No Abstract] [Full Text] [Related]

  • 51. Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice.
    Medhi B, Prakash A.
    Scand J Gastroenterol; 2008 Aug 01; 43(8):1022-3; author reply 1024. PubMed ID: 19086171
    [No Abstract] [Full Text] [Related]

  • 52. Cost-effectiveness of Helicobacter pylori eradication in India: to live and let live ... expensively?
    Bhatia SJ, Kulkarni SG.
    Indian J Gastroenterol; 1997 Nov 01; 16 Suppl 1():S25-8. PubMed ID: 9465500
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Long-term treatment of duodenal ulcer.
    Wormsley KG.
    Postgrad Med J; 1988 Nov 01; 64 Suppl 1():47-53. PubMed ID: 3047725
    [Abstract] [Full Text] [Related]

  • 55. Ebrotidine--a nostrum for ulcer.
    Grover JK, Rathi SS, Vats V.
    Trop Gastroenterol; 1997 Nov 01; 18(3):111-3. PubMed ID: 9385853
    [No Abstract] [Full Text] [Related]

  • 56. [High demands on drug administration and pharmacological principles applied in ulcer diseases].
    Hellström PM.
    Lakartidningen; 1991 Feb 06; 88(6):425-30. PubMed ID: 1671887
    [No Abstract] [Full Text] [Related]

  • 57. Is there really a need for high doses of H2 antagonists in duodenal ulcer treatment?
    Savarino V, Mela GS, Celle G.
    Am J Gastroenterol; 1990 Jul 06; 85(7):903-5. PubMed ID: 1973593
    [No Abstract] [Full Text] [Related]

  • 58. Helicobacter pylori positive resistant duodenal ulcers.
    Tovey FI, Baker L, Jayaraj AP, Yiu YC.
    Gut; 1993 Nov 06; 34(11):1647; author reply 1647-8. PubMed ID: 8244161
    [No Abstract] [Full Text] [Related]

  • 59. [Anti-secretory agents modify the gastric localization of Helicobacter pylori].
    Zaterka S.
    Arq Gastroenterol; 2001 Nov 06; 38(1):1-2. PubMed ID: 11582958
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.